DOV upgraded to Outperform with $240 PT as the ~8% decline following Q2/26 results appears overdone, and BMO sees a path to positive revisio

DOV upgraded to Outperform with $240 PT as the ~8% decline following Q2/26 results appears overdone, and BMO sees a path to positive revisions in 2027 @ BMO